Cutler Group LLC / CA - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 336 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cutler Group LLC / CA ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$4,000
+33.3%
1000.0%0.00%
Q2 2022$3,000
-97.3%
100
-96.8%
0.00%
-100.0%
Q1 2022$112,000
-13.8%
3,100
-27.7%
0.01%
+20.0%
Q4 2021$130,000
+261.1%
4,290
-47.7%
0.01%
+400.0%
Q3 2021$36,000
+12.5%
8,200
+41.4%
0.00%0.0%
Q2 2021$32,0005,800
+480.0%
0.00%
Q4 2020$01,0000.0%0.00%
Q3 2020$0
-100.0%
1,0000.0%0.00%
Q2 2020$2,000
+100.0%
1,0000.0%0.00%
Q1 2020$1,000
-80.0%
1,0000.0%0.00%
Q4 2019$5,000
-16.7%
1,0000.0%0.00%
-100.0%
Q3 2019$6,000
-94.7%
1,000
-90.0%
0.00%
-91.7%
Q1 2019$113,000
+213.9%
10,000
-50.2%
0.01%
+300.0%
Q4 2018$36,000
-48.6%
20,100
+12.9%
0.00%
-25.0%
Q3 2018$70,000
+40.0%
17,800
-6.0%
0.00%0.0%
Q2 2018$50,000
-52.8%
18,930
-20.5%
0.00%
-55.6%
Q1 2018$106,000
-86.7%
23,800
-51.9%
0.01%
-72.7%
Q4 2017$795,000
-40.8%
49,497
-40.3%
0.03%
-34.0%
Q3 2017$1,342,000
+22.1%
82,841
-11.3%
0.05%
+25.0%
Q2 2017$1,099,000
+38.2%
93,447
+30.5%
0.04%
+21.2%
Q1 2017$795,000
-58.4%
71,583
-52.6%
0.03%
-51.5%
Q4 2016$1,913,000
+21.9%
151,012
-12.5%
0.07%
-4.2%
Q3 2016$1,569,000
+18.8%
172,665
+20.0%
0.07%
+6.0%
Q2 2016$1,321,000
-29.1%
143,840
+14.1%
0.07%
-45.5%
Q1 2016$1,864,000
-57.7%
126,028
-47.8%
0.12%
-49.8%
Q4 2015$4,404,000241,6560.24%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Tweedy, Browne Co LLC 3,510,173$159,221,4478.52%
Bellevue Group AG 9,233,700$418,840,6326.75%
Deep Track Capital, LP 2,834,069$128,553,3704.96%
BVF INC/IL 4,004,613$181,649,2464.90%
Sicart Associates LLC 203,132$9,214,0683.61%
Camber Capital Management LP 2,250,000$102,0603.36%
Privium Fund Management B.V. 228,493$10,364,4433.08%
Orbimed Advisors 2,169,500$98,408,5202.09%
SECTOR GAMMA AS 165,616$7,512,3421.92%
TANAKA CAPITAL MANAGEMENT INC 14,612$6631.89%
View complete list of IONIS PHARMACEUTICALS INC shareholders